Retractable Technologies, Inc. (the “Company”) (AMEX: RVP), a leading maker of safety needle medical devices, reported revenues of $10.8 million for the three months ended September 30, 2009, an increase of 19.5% over the same period in 2008. The increase in total revenues from the year-ago quarter was partially due to the sales generated as [...]

Continue reading " Retractable Technologies, Inc. Has 3Q 2009 Revenues Increase 19.5 Percent Over 3Q 2008 "

AGA Medical Holdings (NASDAQ: AGAM), a leading developer of interventional medical devices for the minimally invasive treatment of structural heart defects and vascular disease, reported financial results for the third quarter ended September 30, 2009. Highlights of the third quarter of 2009 and other recent developments include: * Closed its initial public offering on October [...]

Continue reading " AGA Medical Reports 2009 Third Quarter Financial Results "

ZOLL Medical Corporation (Nasdaq GS: ZOLL), a manufacturer of resuscitation devices and related software solutions, announced that the ambulance service, RAV Gooi en Vechtstreek in Hilversum, The Netherlands, is the first EMS organization to equip its ambulances with a revolutionary new system that allows rescuers to defibrillate a heart without the need to stop chest [...]

Continue reading " Dutch Ambulance Service First to Purchase ZOLL Integrated Automated Compression-Defibrillation System "

St. Jude Medical, Inc. (NYSE:STJ) announced European CE Mark approval of its Promote Accel implantable cardiac resynchronization therapy defibrillator (CRT-D). The Promote Accel CRT-D automatically tailors treatment to individual patient needs by measuring the heart’s reaction to therapy and ensuring that the heart is responding, providing the dual benefit of added safety for the patient [...]

Continue reading " St. Jude Medical Announces European Approval of Its Newest Heart Failure Devices Which Enable More Efficient Implantation and Follow-up "